Acute arterial thrombosis in a colon cancer patient after administration of oxaliplatin with capecitabine chemotherapy “case report”
Colorectal cancer is increasing around the world, with many treatment modalities are used in the management of this disease, including surgery, radiotherapy and systemic therapy. The most common chemotherapy agents used in the treatment of colorectal cancer are 5-Fluourouracil (5-FU), Capecitabine,...
Main Authors: | Tala Alawabdeh, Riyad T. Ellati, Rula Amarin, Walid Masoud, Ramiz Abuhijlih |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Current Problems in Cancer: Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666621922000308 |
Similar Items
-
Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
by: Mohammad Ali Mashhadi, et al.
Published: (2016-10-01) -
Relapsed urachal carcinoma responding to first‐line chemotherapy with capecitabine‐oxaliplatin plus bevacizumab
by: Akihiko Hatano, et al.
Published: (2023-11-01) -
Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
by: Renata Ferrarotto, et al.
Published: (2013-09-01) -
First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab
by: Bengang Huo, et al.
Published: (2023-12-01) -
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
by: Anchuan Li, et al.
Published: (2022-07-01)